Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies999
iTind
iTind offers a simple, non-surgical solution for Benign Prostatic Hyperplasia (BPH), improving men's quality of life.
Sector
Subsector
Keywords
Location
total rounds
NuVasive
NuVasive is a medical device company that develops minimally disruptive surgical products and solutions for the spine.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
SpineOvations
SpineOvations is a medical technology company that develops and commercializes products for the diagnosis and treatment of spinal disorders.
Sector
Subsector
Location
total rounds
total raised
NLT SPINE
NLT SPINE develops innovative products for minimally invasive spinal surgery.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Boston Scientific
announced date
price
Financials
Funding Rounds12
Number of Funding Rounds
Money Raised
Their latest funding was raised on 27.03.2017. Their latest investor Alta Partners. Their latest round Venture - Series Unknown
New Enterprise Associates
NEA is a global venture capital firm that helps entrepreneurs build innovative businesses in technology and healthcare.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Alta Partners
Alta Partners is a venture capital firm investing in healthcare and life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners is a Miami-based venture capital firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Endeavour Vision
Endeavour Vision is a private equity firm that invests in growth-stage MedTech and digital health companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors7
Number of lead investors
Number of investors
Alta Partners
Alta Partners is a venture capital firm investing in healthcare and life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Aberdare Ventures
Aberdare Ventures is a venture capital firm that focuses on investing in healthcare technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Morgenthaler Ventures
Morgenthaler Ventures is a venture capital and private equity firm that invests in IT and life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
Earl R. Fender
Mr. Fender has served as the President and CEO since March of 2008. He brings over 25 years of successful leadership experience in general management and product commercialization in the medical device and spinal industry. During a 10 year span, he led DePuy Spine, a Johnson & Johnson company, as Vice President of Sales, U.S. President and finally, Worldwide President. Under Mr. Fender's leadership, DePuy Spine grew to over $1 billion in global sales, operating in 54 countries, making it the world's second largest spinal implant company. Prior to Johnson & Johnson, Mr. Fender led the U.S. sales organization for Synthes (USA), the industry leader in orthopedic trauma, orchestrating a five year period of sales force expansion and accelerated growth. Prior to VertiFlex, Mr. Fender served as Vice President and General Manager of Osiris Therapeutics, Inc., a global leader in adult mesenchymal stem cell technologies. In less than two years, he built Osiris' Osteocel business from scale-up to one of the world's leading commercialized cellular products, which has treated over 15,000 patients. Mr. Fender's academic qualifications include a B.A. in Business Administration from Thiel College, along with the completion of Harvard Business School's Program for Management Development.
current job
organization founded
Earl R. Fender
Employee Profiles7
R. Stephen Reitzler
Vice President, Clinical & Regulatory Affairs
Andy W. Choi
Vice President, Research & Development